Gotowa bibliografia na temat „Osteoclast”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Osteoclast”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Osteoclast"
Yu, Anna Xiao-Dan, Jian Xiao, Shi-Zheng Zhao, Xiang-Peng Kong, Kenneth Kin-Leung Kwan, Brody Zhong-Yu Zheng, Kevin Qi-Yun Wu, Tina Ting-Xia Dong i Karl Wah-Keung Tsim. "Biological Evaluation and Transcriptomic Analysis of Corylin as an Inhibitor of Osteoclast Differentiation". International Journal of Molecular Sciences 22, nr 7 (29.03.2021): 3540. http://dx.doi.org/10.3390/ijms22073540.
Pełny tekst źródłaAlatalo, Sari L., Jussi M. Halleen, Teuvo A. Hentunen, Jukka Mönkkönen i H. Kalervo Väänänen. "Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium". Clinical Chemistry 46, nr 11 (1.11.2000): 1751–54. http://dx.doi.org/10.1093/clinchem/46.11.1751.
Pełny tekst źródłaCombs, Charlotte E., Karen Fuller, Hashethra Kumar, Anthony P. Albert, Grisha Pirianov, James McCormick, Ian C. Locke, Timothy J. Chambers i Kevin M. Lawrence. "Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel". Journal of Endocrinology 212, nr 2 (14.11.2011): 187–97. http://dx.doi.org/10.1530/joe-11-0254.
Pełny tekst źródłaFong, E. L. S., E. L. Prabha i T. Carney. "POS0348 DEVELOPING A WHOLE MOUNT FLUORESCENT OSTEOCLAST ACTIVITY ASSAY USING THE ELF97 PHOSPHATASE SUBSTRATE TO VISUALISE AND QUANTIFY IN SITU OSTEOCLAST ACTIVITY IN ZEBRAFISH (DANIO RERIO)". Annals of the Rheumatic Diseases 81, Suppl 1 (23.05.2022): 427.3–428. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5402.
Pełny tekst źródłaNiida, Shumpei, Masato Kaku, Hitoshi Amano, Hisahiro Yoshida, Hiroshi Kataoka, Satomi Nishikawa, Kazuo Tanne, Norihiko Maeda, Shin-Ichi Nishikawa i Hiroaki Kodama. "Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone Resorption". Journal of Experimental Medicine 190, nr 2 (19.07.1999): 293–98. http://dx.doi.org/10.1084/jem.190.2.293.
Pełny tekst źródłaMoreaux, Jerome, Dirk Hose, Alboukadel Kassambara, Thierry Reme, Philippe Moine, Guilhem Requirand, Hartmut Goldschmidt i Bernard Klein. "Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration". Blood 117, nr 4 (27.01.2011): 1280–90. http://dx.doi.org/10.1182/blood-2010-04-279760.
Pełny tekst źródłaFuller, K., J. M. Owens i T. J. Chambers. "Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts." Journal of Immunology 154, nr 11 (1.06.1995): 6065–72. http://dx.doi.org/10.4049/jimmunol.154.11.6065.
Pełny tekst źródłaPerkins, S. L., i S. J. Kling. "Local concentrations of macrophage colony-stimulating factor mediate osteoclastic differentiation". American Journal of Physiology-Endocrinology and Metabolism 269, nr 6 (1.12.1995): E1024—E1030. http://dx.doi.org/10.1152/ajpendo.1995.269.6.e1024.
Pełny tekst źródłaKameda, Takashi, Hiroshi Mano, Tatsuhisa Yuasa, Yoshihisa Mori, Koshi Miyazawa, Miho Shiokawa, Yukiya Nakamaru i in. "Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts". Journal of Experimental Medicine 186, nr 4 (18.08.1997): 489–95. http://dx.doi.org/10.1084/jem.186.4.489.
Pełny tekst źródłaCheng, Yin, Haixia Liu, Jing Li, Yujie Ma, Changheng Song, Yuhan Wang, Pei Li, Yanjing Chen i Zhiguo Zhang. "Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells". PLOS ONE 17, nr 11 (17.11.2022): e0277871. http://dx.doi.org/10.1371/journal.pone.0277871.
Pełny tekst źródłaRozprawy doktorskie na temat "Osteoclast"
O'Brien, Elizabeth Ann. "Regulation of osteoclast activity : differential adhesion of osteoclasts to the bone surface". Thesis, University of Liverpool, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.343930.
Pełny tekst źródłaStephens, Sebastien. "Novel Osteoclast Signalling". Thesis, Griffith University, 2010. http://hdl.handle.net/10072/365823.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Wilkinson, Debbie Isabelle. "Visualisation of osteoclast membrane domains". Thesis, University of Aberdeen, 2010. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=158808.
Pełny tekst źródłaZaidi, Mone. "Novel mechanisms of osteoclast regulation". Thesis, University of London, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.411434.
Pełny tekst źródłaGu, Xiaomei Everett Eric T. "Physiopathology of osteoclast in bone". Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2008. http://dc.lib.unc.edu/u?/etd,1870.
Pełny tekst źródłaTitle from electronic title page (viewed Dec. 11, 2008). "... in partial fulfillment of the requirements for the degree of Master of Science in the Curriculum of Oral Biology." Discipline: Oral Biology; Department/School: Dentistry.
Barnes, Calvin Langston Toure. "C-mpl Expression in Osteoclast Progenitors: A Novel Role for Thrombopoietin in Regulating Osteoclast Development". Yale University, 2006. http://ymtdl.med.yale.edu/theses/available/etd-06262006-123750/.
Pełny tekst źródłaHale, Annette Julie. "The characterisation of the Pagetic osteoclast". Thesis, University of Nottingham, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359919.
Pełny tekst źródłaLång, Johanna. "CCL11 and Effects on Pre-osteoclast Migration". Thesis, Umeå universitet, Institutionen för odontologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-143797.
Pełny tekst źródłaCombs, Charlotte Emma. "The role of urocortin in osteoclast physiology". Thesis, St George's, University of London, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.517193.
Pełny tekst źródłaMacQuarrie, Robyn Melanie. "Arthroplasty-derived wear particles effect osteoclast differentiation". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/MQ63539.pdf.
Pełny tekst źródłaKsiążki na temat "Osteoclast"
Holt, Ian. Control of osteoclast activity. Manchester: University of Manchester, 1996.
Znajdź pełny tekst źródłaR, Rifkin Barry, i Gay Carol V, red. Biology and physiology of the osteoclast. Boca Raton: CRC Press, 1992.
Znajdź pełny tekst źródłaGreen, Philip Macey. An experimental study of the osteoclast and its role in bone remodelling. Birmingham: University of Birmingham, 1988.
Znajdź pełny tekst źródłaTai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Znajdź pełny tekst źródłaSutton, Michael Mark. The Influence of Microtubules and Microtubule-Based Structures on Osteoclast and CD4+ T Cell Function. [New York, N.Y.?]: [publisher not identified], 2022.
Znajdź pełny tekst źródłaMaria, Bijvoet Olav Leonardus, Lipton Allan i International Cancer Congress (15th : 1990 : Hamburg, Germany), red. Osteoclast inhibition in the management of malignancy-related bone disorders: An international symposium held during the 15th International Cancer Congress, Hamburg, Germany, August 1990. Seattle: Hogrefe & Huber, 1993.
Znajdź pełny tekst źródłaD, Rubens R., i European Conference on Clinical Oncology (5th : 1989 : London, England), red. The Management of bone metastases and hypercalcaemia by osteoclast inhibition: An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto: Hogrefe & Huber, 1990.
Znajdź pełny tekst źródłaYu, Hesheng. P2 purinoceptor-linked Ca2+ signaling and pH changes in osteoclasts. [Toronto: University of Toronto, Faculty of Dentistry], 1996.
Znajdź pełny tekst źródłaFelix, Bronner, Farach-Carson Mary C. 1958- i Rubin Janet, red. Bone resorption. London: Springer, 2005.
Znajdź pełny tekst źródłaRodionova, N. V. Funkt͡s︡ionalʹnai͡a︡ morfologii͡a︡ kletok v osteogeneze. Kiev: Nauk. dumka, 1989.
Znajdź pełny tekst źródłaCzęści książek na temat "Osteoclast"
Pavelka, Margit, i Jürgen Roth. "Osteoclast". W Functional Ultrastructure, 298–99. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-99390-3_153.
Pełny tekst źródłaSchwab, Manfred. "Osteoclast". W Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_4277-2.
Pełny tekst źródłaCrockett, Julie C., David J. Mellis i Adam Taylor. "Transfection of Osteoclasts and Osteoclast Precursors". W Methods in Molecular Biology, 205–22. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-415-5_14.
Pełny tekst źródłaReddy, Sakamuri V., i G. David Roodman. "Osteoclast Differentiation". W The Skeleton, 195–213. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-736-9_14.
Pełny tekst źródłaKrstić, R. V. "Knochengewebe. Osteoclast". W Die Gewebe des Menschen und der Säugetiere, 226–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-61380-7_111.
Pełny tekst źródłaChambers, T. J. "The Osteoclast". W Handbook of Experimental Pharmacology, 353–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55742-2_19.
Pełny tekst źródłaKrstić, Radivoj V. "Bony Tissue. Osteoclast". W General Histology of the Mammal, 226–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70420-8_111.
Pełny tekst źródłaOrriss, Isabel R., i Timothy R. Arnett. "Rodent Osteoclast Cultures". W Methods in Molecular Biology, 103–17. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-415-5_8.
Pełny tekst źródłaYang, Jingxuan, Xiaohong Bi i Min Li. "Osteoclast Differentiation Assay". W Methods in Molecular Biology, 143–48. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8879-2_12.
Pełny tekst źródłaLorenzo, Joseph A. "Osteoclast Precursor Cells". W Advances in Experimental Medicine and Biology, 77–82. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-72009-8_10.
Pełny tekst źródłaStreszczenia konferencji na temat "Osteoclast"
Xuan, W., X. Feng, Y. Shi, F. Wang, M. Zhang i W. Tan. "THU0066 Osteoclast differentiation gene expression profiling reveals ccl4 mediates rankl-induced osteoclast migration". W Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4255.
Pełny tekst źródłaIntemann, J., C. Wehmeyer, V. Kracke, E. Werbenko, P. Paruzel, I. Kramer, M. Kneissel, T. Pap i B. Dankbar. "P081 Sclerostin affects rankl-mediated osteoclast differentiation". W 38th European Workshop for Rheumatology Research, 22–24 February 2018, Geneva, Switzerland. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2018.98.
Pełny tekst źródłaHasegawa, Y., N. M. Nikolaidis, Y. Uehara, L. B. Pitstick, H. Wu, J. C. Gardner, J. G. Noel, E. J. A. Kopras, J. P. Bridges i F. X. McCormack. "Osteoclast-Like Differentiation in Mouse Model of Silicosis". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5413.
Pełny tekst źródłaOliveira, Leandro Gonçalves, Ana Cláudia Gonçalves Lima, Sebastião Alves Pinto, Barbara Elisabeth Schroff, André Maroccolo de Sousa i Juarez Antônio de Sousa. "BREAST CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS: A CASE REPORT". W Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2052.
Pełny tekst źródłaIntemann, J., C. Wehmeyer, DJ de Gorter, V. Kracke, P. Paruzel, I. Kramer, M. Kneissel, T. Pap i B. Dankbar. "P082/O24 Sclerostin deficiency affects RANKL-mediated osteoclast differentiation". W 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.71.
Pełny tekst źródłaHirayama, T., H. Taira, O. Kudo, I. Itonaga, T. Torisu i Y. Fujikawa. "SAT0161 Menatetrenone acts directly on circulating human osteoclast precursors". W Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.648.
Pełny tekst źródłaMonteiro, Karina Miranda, Francianne Rocha Fiel, Nyara Rodrigues Conde de Almeida i Sandrelli dos Reis Carneiro. "GIANT CELL TUMOR OF THE BREAST WITH PULMONARY METASTASIS: A CASE REPORT". W XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1036.
Pełny tekst źródłaSood, Shatakshi, Lisa Patel, Martyn Foster, Louise Jopling, Rob Van’t Hof, Iain Greig, Sam Williams, Iain Mcinnes i Carl Goodyear. "SAT0045 A NOVEL SMALL MOLECULE, MBS2133, MODULATES OSTEOCLAST PRE-CURSOR METABOLISM TO INHIBIT OSTEOCLAST DIFFERENTIATION: AN ALTERNATIVE THERAPY FOR OSTEOLYTIC PATHOLOGY IN RA". W Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.5482.
Pełny tekst źródłaBenabdoune, HA, P. Rondon, Q. Shi, JC Fernandes, H. Fahmi i M. Benderdour. "THU0061 Regulation of osteoclast recruitment and activation by resolvin d1". W Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2934.
Pełny tekst źródłaTanaka, Y., L. B. Pitstick, Y. Hasegawa, H. Wu, E. J. A. Kopras i F. X. McCormack. "Pulmonary Osteoclast-Like Cells Contribute to Asbestos-Induced Pulmonary Fibrosis". W American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4224.
Pełny tekst źródłaRaporty organizacyjne na temat "Osteoclast"
Reddy, Sakamuri. Osteoclast Inhibitory Peptide-1 Therapy for Paget's Disease. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2010. http://dx.doi.org/10.21236/ada539193.
Pełny tekst źródłaReddy, Sakamuri V. Osteoclast Inhibitory Peptide-1 Therapy for Paget's Disease. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2012. http://dx.doi.org/10.21236/ada567774.
Pełny tekst źródłaReddy, Sakamuri. Osteoclast Inhibitory Peptide-1 Therapy for Paget's Disease. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2011. http://dx.doi.org/10.21236/ada553287.
Pełny tekst źródłaReddy, Sakamuri V. Measles Virus Nucleocapsid (MJVNP) Gene Expression and RANK Receptor Signaling in Osteoclast Precursors. Osteoclast Inhibitors Peptide Therapy for Pagets Disease. Fort Belvoir, VA: Defense Technical Information Center, październik 2005. http://dx.doi.org/10.21236/ada484715.
Pełny tekst źródłaReddy, Sakamuri V. Measles Virus Nucleocapsid (MVNP) Gene Expression and RANK Receptor Signaling in Osteoclast Precursors, Osteoclast Inhibitors Peptide Therapy for Pagets Disease. Fort Belvoir, VA: Defense Technical Information Center, październik 2008. http://dx.doi.org/10.21236/ada500887.
Pełny tekst źródłaReddy, Sakamuri V. Measles Virus Nucleocapsid (MVNP) Gene Expression and RANK Receptor Signaling in Osteoclast Precursors, Osteoclast Inhibitors Peptide Therapy for Pagets Disease. Fort Belvoir, VA: Defense Technical Information Center, październik 2006. http://dx.doi.org/10.21236/ada462833.
Pełny tekst źródłaReddy, Sakamuri V. Measles Virus Nucleocapsid (MVNP) Gene Expression and RANK Receptor Signaling in Osteoclast Precursors,Osteoclast Inhibitors Peptide Therapy for Pagets Disease. Fort Belvoir, VA: Defense Technical Information Center, październik 2004. http://dx.doi.org/10.21236/ada482539.
Pełny tekst źródłaMorgans, Alicia K., David F. Penson, Amy J. Graves, Parul Chaudhuri i Daniel Sonnenburg. Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancer. Science Repository OÜ, wrzesień 2018. http://dx.doi.org/10.31487/j.cor.2018.03.001.
Pełny tekst źródłaMorfin, C., i G. G. Loots. Characterizing the role of Mef2c in regulating osteoclast differentiation and energy metabolism. Office of Scientific and Technical Information (OSTI), kwiecień 2018. http://dx.doi.org/10.2172/1459127.
Pełny tekst źródłaGiachelli, Cecilia, Bruce Sangeorzan, Susan Lund, Steven Bain, Cameron Rementer i Dewayne Threet. Engineered Osteoclasts for the Treatment and Prevention of Heterotopic Ossification. Fort Belvoir, VA: Defense Technical Information Center, październik 2014. http://dx.doi.org/10.21236/ada612445.
Pełny tekst źródła